DE69223205D1 - Substituierte Pyridinylamino-1H-Indole, 1H-Indazole, 2H-Indazole, Benzo(b)thiophen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als Arzneimittel - Google Patents
Substituierte Pyridinylamino-1H-Indole, 1H-Indazole, 2H-Indazole, Benzo(b)thiophen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als ArzneimittelInfo
- Publication number
- DE69223205D1 DE69223205D1 DE69223205T DE69223205T DE69223205D1 DE 69223205 D1 DE69223205 D1 DE 69223205D1 DE 69223205 T DE69223205 T DE 69223205T DE 69223205 T DE69223205 T DE 69223205T DE 69223205 D1 DE69223205 D1 DE 69223205D1
- Authority
- DE
- Germany
- Prior art keywords
- indazoles
- loweralkyl
- hydrogen
- compounds
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/764,031 US5185350A (en) | 1991-09-23 | 1991-09-23 | Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69223205D1 true DE69223205D1 (de) | 1998-01-02 |
DE69223205T2 DE69223205T2 (de) | 1998-05-14 |
Family
ID=25069502
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69223205T Expired - Fee Related DE69223205T2 (de) | 1991-09-23 | 1992-09-21 | Substituierte Pyridinylamino-1H-Indole, 1H-Indazole, 2H-Indazole, Benzo(b)thiophen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als Arzneimittel |
Country Status (18)
Country | Link |
---|---|
US (2) | US5185350A (de) |
EP (1) | EP0534343B1 (de) |
JP (1) | JP2961023B2 (de) |
KR (1) | KR930006006A (de) |
AT (1) | ATE160346T1 (de) |
AU (1) | AU653263B2 (de) |
CA (1) | CA2078814C (de) |
CZ (1) | CZ290692A3 (de) |
DE (1) | DE69223205T2 (de) |
DK (1) | DK0534343T3 (de) |
ES (1) | ES2111025T3 (de) |
FI (1) | FI924230A (de) |
GR (1) | GR3025774T3 (de) |
HU (1) | HUT64055A (de) |
IL (1) | IL103232A0 (de) |
MX (1) | MX9205374A (de) |
NO (1) | NO923686L (de) |
TW (1) | TW207539B (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0550507A1 (de) * | 1990-09-13 | 1993-07-14 | Beecham Group p.l.c. | Indolharnstoffe als 5ht rezeptor-antagonist |
US5356910A (en) | 1993-07-19 | 1994-10-18 | Hoechst-Roussel Pharmaceuticals Inc. | Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder |
CA2176127A1 (en) * | 1993-12-21 | 1995-06-29 | William Henry Walker Lunn | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
DE19626373A1 (de) * | 1996-07-02 | 1998-01-08 | Boehringer Ingelheim Kg | Neuartige Verwendung von Wirkstoffen, welche die Funktion von nichtneuronalem Acetylcholin beeinflussen |
TW200302722A (en) * | 2002-02-13 | 2003-08-16 | Astrazeneca Ab | Therapeutic agents |
US20050222123A1 (en) | 2004-01-27 | 2005-10-06 | North Shore-Long Island Jewish Research Institute | Cholinesterase inhibitors for treating inflammation |
JP4857128B2 (ja) | 2004-02-20 | 2012-01-18 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | 新規な化合物 |
JP4787471B2 (ja) * | 2004-05-21 | 2011-10-05 | 株式会社ポッカコーポレーション | 脳機能亢進剤 |
AU2005250116B2 (en) | 2004-06-01 | 2011-01-20 | F. Hoffmann-La Roche Ag | 3-amino-1-arylpropyl indoles as monoamine reuptake inhibitor |
CA2632284A1 (en) | 2005-11-30 | 2007-06-07 | F. Hoffmann-La Roche Ag | 3-amino-2-arylpropyl azaindoles and uses thereof |
CN101316818B (zh) | 2005-11-30 | 2011-08-31 | 弗·哈夫曼-拉罗切有限公司 | 3-氨基-1-芳基丙基吲哚类和氮杂取代的吲哚类 |
EP2351737A1 (de) * | 2005-11-30 | 2011-08-03 | F. Hoffmann-La Roche AG | 3-Amino-1-arylpropyl-Indole und aza-substituierte Indole |
KR102534969B1 (ko) * | 2021-08-20 | 2023-05-26 | 김수영 | 포켓 인슐레이터 및 이를 포함하는 단열체 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3852335T2 (de) * | 1987-04-24 | 1995-05-11 | Hoechst Roussel Pharma | N-(Pyridinyl)-1H-indol-1-amine, Verfahren zu deren Herstellung und ihre Verwendung als Arzneimittel. |
US4970219A (en) * | 1989-06-28 | 1990-11-13 | Hoechst-Roussel Pharmaceuticals Inc. | Heteroarylamino- and heteroaryloxypyridinamine compounds which have useful utility in treating skin disorders |
US4983615A (en) * | 1989-06-28 | 1991-01-08 | Hoechst-Roussel Pharmaceuticals Inc. | Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders |
US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
-
1991
- 1991-09-23 US US07/764,031 patent/US5185350A/en not_active Expired - Fee Related
-
1992
- 1992-09-10 TW TW081107145A patent/TW207539B/zh active
- 1992-09-21 AT AT92116110T patent/ATE160346T1/de not_active IP Right Cessation
- 1992-09-21 DK DK92116110T patent/DK0534343T3/da active
- 1992-09-21 FI FI924230A patent/FI924230A/fi unknown
- 1992-09-21 IL IL103232A patent/IL103232A0/xx unknown
- 1992-09-21 EP EP92116110A patent/EP0534343B1/de not_active Expired - Lifetime
- 1992-09-21 DE DE69223205T patent/DE69223205T2/de not_active Expired - Fee Related
- 1992-09-21 ES ES92116110T patent/ES2111025T3/es not_active Expired - Lifetime
- 1992-09-22 NO NO92923686A patent/NO923686L/no unknown
- 1992-09-22 KR KR1019920017238A patent/KR930006006A/ko not_active Application Discontinuation
- 1992-09-22 AU AU25297/92A patent/AU653263B2/en not_active Expired - Fee Related
- 1992-09-22 CA CA002078814A patent/CA2078814C/en not_active Expired - Lifetime
- 1992-09-22 HU HU9203023A patent/HUT64055A/hu unknown
- 1992-09-22 CZ CS922906A patent/CZ290692A3/cs unknown
- 1992-09-22 JP JP4251779A patent/JP2961023B2/ja not_active Expired - Fee Related
- 1992-09-22 MX MX9205374A patent/MX9205374A/es not_active IP Right Cessation
-
1993
- 1993-03-25 US US08/038,317 patent/US5328918A/en not_active Expired - Lifetime
-
1997
- 1997-12-23 GR GR970403425T patent/GR3025774T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2529792A (en) | 1993-03-25 |
EP0534343B1 (de) | 1997-11-19 |
US5328918A (en) | 1994-07-12 |
CA2078814C (en) | 2003-09-09 |
MX9205374A (es) | 1993-03-01 |
DK0534343T3 (da) | 1998-07-27 |
GR3025774T3 (en) | 1998-03-31 |
AU653263B2 (en) | 1994-09-22 |
CA2078814A1 (en) | 1993-03-24 |
JPH061787A (ja) | 1994-01-11 |
HU9203023D0 (en) | 1993-11-29 |
ES2111025T3 (es) | 1998-03-01 |
FI924230A (fi) | 1993-03-24 |
CZ290692A3 (en) | 1993-04-14 |
KR930006006A (ko) | 1993-04-20 |
NO923686D0 (no) | 1992-09-22 |
TW207539B (de) | 1993-06-11 |
IL103232A0 (en) | 1993-02-21 |
US5185350A (en) | 1993-02-09 |
NO923686L (no) | 1993-03-24 |
JP2961023B2 (ja) | 1999-10-12 |
FI924230A0 (fi) | 1992-09-21 |
EP0534343A1 (de) | 1993-03-31 |
HUT64055A (en) | 1993-11-29 |
ATE160346T1 (de) | 1997-12-15 |
DE69223205T2 (de) | 1998-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69223205D1 (de) | Substituierte Pyridinylamino-1H-Indole, 1H-Indazole, 2H-Indazole, Benzo(b)thiophen und 1,2-Benzisothiazole, Verfahren zu ihren Herstellung und ihre Verwendung als Arzneimittel | |
ATE169622T1 (de) | Heteroarylamino- und heteroaryloxypyridinamine und verwandte verbindungen, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel | |
DE69031259D1 (de) | Mit Physostigmine verwandte N-aminocarbamate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
ATE67189T1 (de) | Alpha-alkyl-4-amino-3-chinolin-methanole und 1-(4-aralkylamino-3-chinolyl)alkanone, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
DE69223837D1 (de) | Substituierte 3-(Pyridinylamino)-indole und Benzo[b]thiophene, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
DE69206889D1 (de) | Arylalkylpiperidine-4-yl)methyl]-2-alpha-3,4,5-tetrahydro-1-(2H)-acenaphthylene-1-Onederivate, ein Verfahren für ihre Herstellung und ihre Verwendung als Medikamente | |
ATE140006T1 (de) | 1-(pyrido(3,4-b>-1,4-oxazinyl-4-yl)-1h-indole, zwischenprodukte und ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
DE3780015T2 (de) | Kondensierte heterocyclische tetrahydroaminochinolinole und verwandte verbindungen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
ATE79118T1 (de) | N-pyridinyl-9h-carbazol-9-amine, verfahren zu ihrer herstellung und ihre verwendung als medikamente. | |
DE68918402D1 (de) | 1,2,3,4-Tetrahydro-1,9-Acridindiamine, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. | |
ATE115133T1 (de) | (1,2,3,4-tetrahydro-9-acridinimino)cyclohexan- carbonsäure und verwandte verbindungen, ein verfahren zu ihrer herstellung und ihre verwendung als medikamente. | |
ATE104298T1 (de) | Kondensierte heterocyclische derivate von 1,2,3,4-tetrahydroacridin, verfahren zu ihrer herstellung und ihre verwendung als medikament. | |
DE69019066T2 (de) | 4,5,5a,6-Tetrahydro-3H-isoxyzolo(5,4,3-k1)acridinderivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |